Clinical Trial Update: MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating MDMA-assisted Cognitive-Behavioral Conjoint Therapy for PTSD in dyads where one member has chronic PTSD; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-19